The active pharmaceutical ingredient (API) in a medication is the component that causes the desired effects. Active pharmaceutical ingredients are mostly manufactured at big manufacturing factories and its manufacturing process involves a series of operations such as multi-step chemical synthesis, fermentation, purification, crystallization, drying, milling, packing, labeling, and testing. They may also be examined by foreign government agencies, and third-party corporations may conduct audits at API facilities. APIs must meet the quality and safety requirements imposed by the producing country. Even if the production is outsourced, API businesses must adhere to the rigorous requirements of the relevant health authorities. Most of the active pharmaceutical ingredient companies are headquartered in India. However, because the bulk API production takes place in mostly Asian countries such as China, they are the source of the majority of APIs produced worldwide.
Market Dynamics
The active pharmaceutical ingredients manufacturers are starting production units in India to remain competitive and gain benefit over other competitors, which is projected to fuel the market growth during the forecast period. For instance, in February 2017, Nacto pharma, an Indian multinational pharmaceutical company, planned to invest around US$ 1 Billion and expand its active pharmaceutical ingredient (API) and intermediates manufacturing facility in Tamil Nadu.
Key features of the study:
- This report provides an in-depth analysis of the India active pharmaceutical ingredient market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the India active pharmaceutical ingredients market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Salora, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Lupin Limited, Sun Pharmaceutical Industries Limited, Divi’s Laboratories Ltd., Aarti Drugs Ltd., Hikal Ltd., Neuland Labs, Century Pharmaceuticals Ltd., Proventus Life Sciences Pvt Ltd, Chiral Drugs Pvt Ltd, USV Private Limited, and ASolution Pharmaceuticals Pvt. Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The India active pharmaceutical ingredient market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the India active pharmaceutical ingredient market
Detailed Segmentation:
- India Active Pharmaceutical Ingredient Market, By Product Type:
- Low Potent APIs
- High Potent APIs
- India Active Pharmaceutical Ingredient Market, By Molecular Type:
- Acetaminophen
- Naproxen
- Dextromethorphan Hydrobromide
- Gabapentin
- Ciprofloxacin
- Ofloxacin
- Mirtazapine
- Sotalol
- Levetiracetam
- Salmeterol
- Salbutamol
- Fexuprazan
- Diclofenac
- Azithromycin
- Afatinib dimaleate
- Apixaban
- Bendamustine
- Bosentan Monohydrate
- Atorvastin Calcium
- Atorvastin Calcium
- Ibuprofen
- Praziquantel
- Oseltamivir - Process A
- Lanthanum Carbonate Octa
- Sevelamer Carbonate
- Succinyl Choline Chloride
- Others
- India Active Pharmaceutical Ingredient Market, By Formulation:
- Oral
- Topical
- Injectables
- Drops
- India Active Pharmaceutical Ingredient Market, By Application:
- Diabetes
- Oncology
- Cardiovascular
- CNS
- Analgesics
- Dermatology
- Respiratory
- Ophthalmic
- Others
- India Active Pharmaceutical Ingredient Market, By Region:
- North India
- By Product Type
- Low Potent APIs
- High Potent APIs
- By Molecular Type
- Acetaminophen
- Naproxen
- Dextromethorphan Hydrobromide
- Gabapentin
- Ciprofloxacin
- Ofloxacin
- Mirtazapine
- Sotalol
- Levetiracetam
- Salmeterol
- Salbutamol
- Fexuprazan
- Diclofenac
- Azithromycin
- Afatinib dimaleate
- Apixaban
- Bendamustine
- Bosentan Monohydrate
- Atorvastin Calcium
- Atorvastin Calcium
- Ibuprofen
- Praziquantel
- Oseltamivir - Process A
- Lanthanum Carbonate Octa
- Sevelamer Carbonate
- Succinyl Choline Chloride
- Others
- By Formulation
- Oral
- Topical
- Injectables
- Drops
- By Application
- Diabetes
- Oncology
- Cardiovascular
- CNS
- Analgesics
- Dermatology
- Respiratory
- Ophthalmic
- Others
- By States
- Delhi
- Uttar Pradesh
- Rajasthan
- Punjab
- Others
- South India
- By Product Type
- Low Potent APIs
- High Potent APIs
- By Molecular Type
- Acetaminophen
- Naproxen
- Dextromethorphan Hydrobromide
- Gabapentin
- Ciprofloxacin
- Ofloxacin
- Mirtazapine
- Sotalol
- Levetiracetam
- Salmeterol
- Salbutamol
- Fexuprazan
- Diclofenac
- Azithromycin
- Afatinib dimaleate
- Apixaban
- Bendamustine
- Bosentan Monohydrate
- Atorvastin Calcium
- Atorvastin Calcium
- Ibuprofen
- Praziquantel
- Oseltamivir - Process A
- Lanthanum Carbonate Octa
- Sevelamer Carbonate
- Succinyl Choline Chloride
- Others
- By Formulation
- Oral
- Topical
- Injectables
- Drops
- By Application
- Diabetes
- Oncology
- Cardiovascular
- CNS
- Analgesics
- Dermatology
- Respiratory
- Ophthalmic
- Others
- By States
- Tamil Nadu
- Kerala
- Andhra Pradesh
- Telangana
- Others
- East India
- By Product Type
- Low Potent APIs
- High Potent APIs
- By Molecular Type
- Acetaminophen
- Naproxen
- Dextromethorphan Hydrobromide
- Gabapentin
- Ciprofloxacin
- Ofloxacin
- Mirtazapine
- Sotalol
- Levetiracetam
- Salmeterol
- Salbutamol
- Fexuprazan
- Diclofenac
- Azithromycin
- Afatinib dimaleate
- Apixaban
- Bendamustine
- Bosentan Monohydrate
- Atorvastin Calcium
- Atorvastin Calcium
- Ibuprofen
- Praziquantel
- Oseltamivir - Process A
- Lanthanum Carbonate Octa
- Sevelamer Carbonate
- Succinyl Choline Chloride
- Others
- By Formulation
- Oral
- Topical
- Injectables
- Drops
- By Application
- Diabetes
- Oncology
- Cardiovascular
- CNS
- Analgesics
- Dermatology
- Respiratory
- Ophthalmic
- Others
- By States
- Bihar
- Jharkhand
- West Bengal
- Others (North East India)
- West India
- By Product Type
- Low Potent APIs
- High Potent APIs
- By Molecular Type
- Acetaminophen
- Naproxen
- Dextromethorphan Hydrobromide
- Gabapentin
- Ciprofloxacin
- Ofloxacin
- Mirtazapine
- Sotalol
- Levetiracetam
- Salmeterol
- Salbutamol
- Fexuprazan
- Diclofenac
- Azithromycin
- Afatinib dimaleate
- Apixaban
- Bendamustine
- Bosentan Monohydrate
- Atorvastin Calcium
- Atorvastin Calcium
- Ibuprofen
- Praziquantel
- Oseltamivir - Process A
- Lanthanum Carbonate Octa
- Sevelamer Carbonate
- Succinyl Choline Chloride
- Others
- By Formulation
- Oral
- Topical
- Injectables
- Drops
- By Application
- Diabetes
- Oncology
- Cardiovascular
- CNS
- Analgesics
- Dermatology
- Respiratory
- Ophthalmic
- Others
- By States
- Central India
- By Product Type
- Low Potent APIs
- High Potent APIs
- By Molecular Type
- Acetaminophen
- Naproxen
- Dextromethorphan Hydrobromide
- Gabapentin
- Ciprofloxacin
- Ofloxacin
- Mirtazapine
- Sotalol
- Levetiracetam
- Salmeterol
- Salbutamol
- Fexuprazan
- Diclofenac
- Azithromycin
- Afatinib dimaleate
- Apixaban
- Bendamustine
- Bosentan Monohydrate
- Atorvastin Calcium
- Atorvastin Calcium
- Ibuprofen
- Praziquantel
- Oseltamivir - Process A
- Lanthanum Carbonate Octa
- Sevelamer Carbonate
- Succinyl Choline Chloride
- Others
- By Formulation
- Oral
- Topical
- Injectables
- Drops
- By Application
- Diabetes
- Oncology
- Cardiovascular
- CNS
- Analgesics
- Dermatology
- Respiratory
- Ophthalmic
- Others
- By States
- Madhya Pradesh
- Chhattisgarh
- Company Profiles
-
- Teva Pharmaceutical Industries Ltd *
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Salora
- Aurobindo Pharma Limited
- Reddy's Laboratories
- Lupin Limited
- Sun Pharmaceutical Industries Limited
- Divi’s Laboratories Ltd.
- Aarti Drugs Ltd.
- Hikal Ltd.
- Neuland Labs
- Century Pharmaceuticals Ltd.
- Proventus Life Sciences Pvt Ltd
- Chiral Drugs Pvt Ltd
- USV Private Limited
- ASolution Pharmaceuticals Pvt. Ltd.
“*” marked represents similar segmentation in other categories in the respective section.